查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786875

生物标记市场，规模，占有率，趋势，产业分析:各类型，各研究领域，各技术，各疾病适应症，各用途，各地区，2025年～2034年的市场预测

Biomarkers Market Size, Share, Trends, & Industry Analysis By Type, (Safety Biomarkers, Efficacy Biomarkers, and Validation Biomarkers), By Research Area, By Technology, By Disease Indication, By Application, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，生物标记市场规模将达到 1,467.8 亿美元。本研究报告深入分析了当前的市场动态，并分析了未来的市场成长。

全球生物标记市场持续扩张，这得益于其在临床诊断、药物研究和健康监测过程中的广泛应用。蛋白质、基因和代谢物等生物标记检测是衡量健康状况和疾病存在与否的生物指标。血液、组织和尿液样本通常用于实验室分析这些指标，以用于医疗和研究目的。

医院、诊断实验室和研究中心扩大采用生物标记进行常规健康评估和高级临床评估。随着实验室方法日益复杂且易于获取，生物标记在改善临床工作流程和支援更明智医疗决策方面的作用日益增强。

生物标记市场报告重点

按研究领域划分，基因组学在2024年占据市场领先地位，这主要归功于其在检测基因变异、评估疾病易感性以及在各个治疗领域实现精准医疗方法方面的广泛应用。

在技术方面，预计下一代定序技术将在预测期内经历最快的市场扩张。这种加速成长反映了NGS无与伦比的高通量基因组分析能力，有助于全面发现生物标记。

预计北美将在2024年占据生物标记市场的最大占有率，这得益于该地区创新生物製药公司和先进诊断实验室的集中，以及对精准医疗研发计划的大量投资。

预计亚太地区的生物标记市场将在预测期内实现最高成长率，这得益于医疗基础设施的快速改善、先进诊断技术的日益普及以及新兴经济体生物医学研究能力的不断提升。

全球主要市场参与者包括雅培实验室、安捷伦科技公司、生物梅里埃公司、Bio-Rad Laboratories, Inc.、Charles River Laboratories International, Inc.、Eurofins Scientific SE、F. Hoffmann-La Roche Ltd.、Guardant Health, Inc.、Illumina, Inc.、默克集团、凯杰公司和 Revvity, Inc.

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球生物标记市场洞察

  • 市场概述
  • 生物标记市场动态
    • 促进因素和机会
      • 慢性病盛行率上升
      • 基因体学和蛋白质体学的进展
    • 限制与课题
      • 生物标记验证和开发的高成本
      • 监理不确定性与冗长的审批流程
  • PESTEL分析
  • 生物标记市场趋势
  • 价值链分析

第5章 全球生物标记市场:各类型

  • 主要调查结果
  • 简介
  • 安全性生物标记
  • 有效性生物标记
  • 检验生物标记

第6章 全球生物标记市场:各研究领域

  • 主要调查结果
  • 简介
  • 基因学
  • 蛋白质体学
  • 代谢体学
  • 其他的研究领域

第7章 全球生物标记市场:各技术

  • 主要调查结果
  • 简介
  • 免疫检测
  • 次世代定序(NGS)
  • 聚合酵素链锁反应(PCR)
  • 质谱分析
  • 层析法
  • 其他技术

第8章 全球生物标记市场:各疾病适应症

  • 主要调查结果
  • 简介
  • 癌症
  • 感染疾病
  • 免疫疾病
  • 政府及公共部门
  • 神经疾病
  • 心血管疾病
  • 其他的疾病适应症

第9章 全球生物标记市场:各用途

  • 主要调查结果
  • 简介
  • 临床诊断
  • 医药品的发现与开发
  • 个性化医疗
  • 临床调查
  • 其他的用途

第10章 全球生物标记市场:各地区

  • 主要调查结果
  • 简介
    • 生物标记市场评估:各地区，2020～2034年
  • 北美
    • 北美:各类型，2020～2034年
    • 北美:各研究领域，2020～2034年
    • 北美:各技术，2020～2034年
    • 北美:各疾病适应症，2020～2034年
    • 北美:各用途，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各类型，2020～2034年
    • 欧洲:各研究领域，2020～2034年
    • 欧洲:各技术，2020～2034年
    • 欧洲:各疾病适应症，2020～2034年
    • 欧洲:各用途，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各类型，2020～2034年
    • 亚太地区:各研究领域，2020～2034年
    • 亚太地区:各技术，2020～2034年
    • 亚太地区:各疾病适应症，2020年～2034年
    • 亚太地区:各用途，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各类型，2020～2034年
    • 中东·非洲:各研究领域，2020～2034年
    • 中东·非洲:各技术，2020～2034年
    • 中东·非洲:各疾病适应症，2020年～2034年
    • 中东·非洲:各用途，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲
  • 南美
    • 南美:各类型，2020～2034年
    • 南美:各研究领域，2020～2034年
    • 南美:各技术，2020～2034年
    • 南美:各疾病适应症，2020年～2034年
    • 南美:各用途，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第11章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第12章 企业简介

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • BioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Merck KGaA
  • QIAGEN N.V.
  • Revvity, Inc.
Product Code: PM5934

The biomarkers market size is expected to reach USD 146.78 Billion by 2034, according to a new study by Polaris Market Research. The report "Biomarkers Market Size, Share, Trends, & Industry Analysis By Type, (Safety Biomarkers, Efficacy Biomarkers, and Validation Biomarkers), By Research Area, By Technology, By Disease Indication, By Application, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global biomarkers market continues to expand due to its growing use across clinical diagnostics, pharmaceutical research, and health monitoring processes. Biomarkers such as proteins, genes, and metabolites assays serve as biological indicators to measure health status or disease presence. Samples such as blood, tissue, and urine are typically used in laboratory settings to analyze these indicators for medical or research purposes.

The adoption of biomarkers is increasing in general health assessments and advanced clinical evaluations across hospitals, diagnostic labs, and research centers. The role of biomarkers in improving clinical workflows and supporting more informed medical decisions continues to grow as laboratory methods become more refined and accessible.

Biomarkers Market Report Highlights

Based on research area, the genomics segment held the leading market position in 2024, primarily due to its extensive application in detecting genetic variations, assessing disease susceptibility, and enabling precision medicine approaches across therapeutic areas.

In terms of technology, the next-generation sequencing technology is anticipated to experience the most rapid market expansion during the forecast period. This accelerated growth reflects NGS's unparalleled capacity for high-throughput genomic analysis, which facilitates comprehensive biomarker discovery

North America captured the largest share of the biomarkers market in 2024, a position supported by the region's concentration of innovative biopharmaceutical firms, advanced diagnostic laboratories, and substantial investments in precision medicine research and development initiatives.

The Asia Pacific biomarkers market is forecast to demonstrate the highest growth rate during the projection period, driven by rapid improvements in healthcare infrastructure, increasing adoption of advanced diagnostic technologies, and expanding capabilities in biomedical research across emerging economies in the region.

A few global key market players include Abbott Laboratories, Agilent Technologies, Inc., BioMerieux SA, Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Guardant Health, Inc., Illumina, Inc., Merck KGaA, QIAGEN N.V., Revvity, Inc.

Polaris Market Research has segmented the market report on the basis of type, research area, technology, disease indication, application, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

Safety Biomarkers

Efficacy Biomarkers

Validation Biomarkers

By Research Area Outlook (Revenue, USD Billion, 2020-2034)

Genomics

Proteomics

Metabolomics

Other Research Areas

By Technology Outlook (Revenue, USD Billion, 2020-2034)

Immunoassays

Next-Generation Sequencing (NGS)

Polymerase Chain Reaction (PCR)

Mass Spectrometry

Chromatography

Other Technologies

By Disease Indication Outlook (Revenue, USD Billion, 2020-2034)

Cancer

Infectious Disease

Immunological Disorders

Neurological Disorders

Cardiovascular Disorders

Other Disease Indications

By Application Outlook (Revenue, USD Billion, 2020-2034)

Clinical Diagnostics

Drug Discovery & Development

Personalized Medicine

Clinical Research

Other Application

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Biomarkers Market Insights

  • 4.1. Biomarkers Market - Market Snapshot
  • 4.2. Biomarkers Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Chronic Diseases
      • 4.2.1.2. Advancements in Genomics and Proteomics
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Biomarker Validation and Development
      • 4.2.2.2. Regulatory Uncertainty and Lengthy Approval Processes
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Biomarkers Market Trends
  • 4.6. Value Chain Analysis

5. Global Biomarkers Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Safety Biomarkers
    • 5.3.1. Global Biomarkers Market, by Safety Biomarkers, by Region, 2020-2034 (USD Billion)
  • 5.4. Efficacy Biomarkers
      • 5.4.1.1. Global Biomarkers Market, by Efficacy Biomarkers, by Region, 2020-2034 (USD Billion)
    • 5.4.2. Global Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • 5.5. Validation Biomarkers
    • 5.5.1. Global Biomarkers Market, by Validation Biomarkers, by Region, 2020-2034 (USD Billion)

6. Global Biomarkers Market, by Research Area

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • 6.3. Genomics
    • 6.3.1. Global Biomarkers Market, by Genomics, by Region, 2020-2034 (USD Billion)
  • 6.4. Proteomics
    • 6.4.1. Global Biomarkers Market, by Proteomics, by Region, 2020-2034 (USD Billion)
  • 6.5. Metabolomics
    • 6.5.1. Global Biomarkers Market, by Metabolomics, by Region, 2020-2034 (USD Billion)
  • 6.6. Other Research Areas
    • 6.6.1. Global Biomarkers Market, by Other Research Areas, by Region, 2020-2034 (USD Billion)

7. Global Biomarkers Market, by Technology

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • 7.3. Immunoassays
    • 7.3.1. Global Biomarkers Market, by Immunoassays, by Region, 2020-2034 (USD Billion)
  • 7.4. Next-Generation Sequencing (NGS)
    • 7.4.1. Global Biomarkers Market, by Next-Generation Sequencing (NGS), by Region, 2020-2034 (USD Billion)
  • 7.5. Polymerase Chain Reaction (PCR)
    • 7.5.1. Global Biomarkers Market, by Polymerase Chain Reaction (PCR), by Region, 2020-2034 (USD Billion)
  • 7.6. Mass Spectrometry
    • 7.6.1. Global Biomarkers Market, by Mass Spectrometry, by Region, 2020-2034 (USD Billion)
  • 7.7. Chromatography
    • 7.7.1. Global Biomarkers Market, by Chromatography, by Region, 2020-2034 (USD Billion)
  • 7.8. Other Technologies
    • 7.8.1. Global Biomarkers Market, by Other Technologies, by Region, 2020-2034 (USD Billion)

8. Global Biomarkers Market, by Disease Indication

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • 8.3. Cancer
    • 8.3.1. Global Biomarkers Market, by Cancer, by Region, 2020-2034 (USD Billion)
  • 8.4. Infectious Disease
    • 8.4.1. Global Biomarkers Market, by Infectious Disease, by Region, 2020-2034 (USD Billion)
  • 8.5. Immunological Disorders
    • 8.5.1. Global Biomarkers Market, by Immunological Disorders, by Region, 2020-2034 (USD Billion)
  • 8.6. Government & Public Sector
    • 8.6.1. Global Biomarkers Market, by Government & Public Sector, by Region, 2020-2034 (USD Billion)
  • 8.7. Neurological Disorders
    • 8.7.1. Global Biomarkers Market, by Neurological Disorders, by Region, 2020-2034 (USD Billion)
  • 8.8. Cardiovascular Disorders
    • 8.8.1. Global Biomarkers Market, by Cardiovascular Disorders, by Region, 2020-2034 (USD Billion)
  • 8.9. Other Disease Indications
    • 8.9.1. Global Biomarkers Market, by Other Disease Indications, by Region, 2020-2034 (USD Billion)

9. Global Biomarkers Market, by Application

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 9.3. Clinical Diagnostics
    • 9.3.1. Global Biomarkers Market, by Clinical Diagnostics, by Region, 2020-2034 (USD Billion)
  • 9.4. Drug Discovery & Development
    • 9.4.1. Global Biomarkers Market, by Drug Discovery & Development, by Region, 2020-2034 (USD Billion)
  • 9.5. Personalized Medicine
    • 9.5.1. Global Biomarkers Market, by Personalized Medicine, by Region, 2020-2034 (USD Billion)
  • 9.6. Clinical Research
    • 9.6.1. Global Biomarkers Market, by Clinical Research, by Region, 2020-2034 (USD Billion)
  • 9.7. Other Application
    • 9.7.1. Global Biomarkers Market, by Other Application, by Region, 2020-2034 (USD Billion)

10. Global Biomarkers Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Biomarkers Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 10.3. Biomarkers Market - North America
    • 10.3.1. North America: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.3.2. North America: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.3.3. North America: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.3.4. North America: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.3.5. North America: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.3.6. Biomarkers Market - U.S.
      • 10.3.6.1. U.S.: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.3.6.2. U.S.: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.3.6.3. U.S.: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.3.6.4. U.S.: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.3.6.5. U.S.: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.3.7. Biomarkers Market - Canada
      • 10.3.7.1. Canada: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.3.7.2. Canada: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.3.7.3. Canada: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.3.7.4. Canada: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.3.7.5. Canada: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.4. Biomarkers Market - Europe
    • 10.4.1. Europe: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.4.2. Europe: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.4.3. Europe: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.4.4. Europe: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.4.5. Europe: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.4.6. Biomarkers Market - UK
      • 10.4.6.1. UK: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.4.6.2. UK: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.4.6.3. UK: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.6.4. UK: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.6.5. UK: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.4.7. Biomarkers Market - France
      • 10.4.7.1. France: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.4.7.2. France: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.4.7.3. France: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.7.4. France: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.7.5. France: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.4.8. Biomarkers Market - Germany
      • 10.4.8.1. Germany: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.4.8.2. Germany: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.4.8.3. Germany: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.8.4. Germany: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.8.5. Germany: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.4.9. Biomarkers Market - Italy
      • 10.4.9.1. Italy: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.4.9.2. Italy: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.4.9.3. Italy: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.9.4. Italy: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.9.5. Italy: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.4.10. Biomarkers Market - Spain
      • 10.4.10.1. Spain: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.4.10.2. Spain: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.4.10.3. Spain: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.10.4. Spain: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.10.5. Spain: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.4.11. Biomarkers Market - Netherlands
      • 10.4.11.1. Netherlands: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.4.11.2. Netherlands: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.4.11.3. Netherlands: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.11.4. Netherlands: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.11.5. Netherlands: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.4.12. Biomarkers Market - Russia
      • 10.4.12.1. Russia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.4.12.2. Russia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.4.12.3. Russia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.12.4. Russia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.12.5. Russia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.4.13. Biomarkers Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.4.13.2. Rest of Europe: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.4.13.3. Rest of Europe: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.4.13.4. Rest of Europe: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.4.13.5. Rest of Europe: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.5. Biomarkers Market - Asia Pacific
    • 10.5.1. Asia Pacific: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.5.2. Asia Pacific: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.5.3. Asia Pacific: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.5.4. Asia Pacific: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.5.5. Asia Pacific: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.5.6. Biomarkers Market - China
      • 10.5.6.1. China: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.5.6.2. China: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.5.6.3. China: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.6.4. China: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.6.5. China: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.5.7. Biomarkers Market - India
      • 10.5.7.1. India: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.5.7.2. India: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.5.7.3. India: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.7.4. India: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.7.5. India: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.5.8. Biomarkers Market - Malaysia
      • 10.5.8.1. Malaysia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.5.8.2. Malaysia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.5.8.3. Malaysia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.8.4. Malaysia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.8.5. Malaysia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.5.9. Biomarkers Market - Japan
      • 10.5.9.1. Japan: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.5.9.2. Japan: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.5.9.3. Japan: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.9.4. Japan: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.9.5. Japan: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.5.10. Biomarkers Market - Indonesia
      • 10.5.10.1. Indonesia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.5.10.2. Indonesia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.5.10.3. Indonesia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.10.4. Indonesia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.10.5. Indonesia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.5.11. Biomarkers Market - South Korea
      • 10.5.11.1. South Korea: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.5.11.2. South Korea: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.5.11.3. South Korea: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.11.4. South Korea: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.11.5. South Korea: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.5.12. Biomarkers Market - Australia
      • 10.5.12.1. Australia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.5.12.2. Australia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.5.12.3. Australia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.12.4. Australia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.12.5. Australia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.5.13. Biomarkers Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.5.13.2. Rest of Asia Pacific: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.5.13.3. Rest of Asia Pacific: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.5.13.4. Rest of Asia Pacific: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.5.13.5. Rest of Asia Pacific: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.6. Biomarkers Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.6.2. Middle East & Africa: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.6.3. Middle East & Africa: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.6.4. Middle East & Africa: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.6.5. Middle East & Africa: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.6.6. Biomarkers Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.6.6.2. Saudi Arabia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.6.7. Biomarkers Market - UAE
      • 10.6.7.1. UAE: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.6.7.2. UAE: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.6.7.3. UAE: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.6.7.4. UAE: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.6.7.5. UAE: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.6.8. Biomarkers Market - Israel
      • 10.6.8.1. Israel: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.6.8.2. Israel: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.6.8.3. Israel: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.6.8.4. Israel: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.6.8.5. Israel: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.6.9. Biomarkers Market - South Africa
      • 10.6.9.1. South Africa: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.6.9.2. South Africa: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.6.9.3. South Africa: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.6.9.4. South Africa: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.6.9.5. South Africa: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.6.10. Biomarkers Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.6.10.2. Rest of Middle East & Africa: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.6.10.3. Rest of Middle East & Africa: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.6.10.4. Rest of Middle East & Africa: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.6.10.5. Rest of Middle East & Africa: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • 10.7. Biomarkers Market - Latin America
    • 10.7.1. Latin America: Biomarkers Market, by Type, 2020-2034 (USD Billion)
    • 10.7.2. Latin America: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
    • 10.7.3. Latin America: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
    • 10.7.4. Latin America: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
    • 10.7.5. Latin America: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.7.6. Biomarkers Market - Mexico
      • 10.7.6.1. Mexico: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.7.6.2. Mexico: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.7.6.3. Mexico: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.7.6.4. Mexico: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.7.6.5. Mexico: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.7.7. Biomarkers Market - Brazil
      • 10.7.7.1. Brazil: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.7.7.2. Brazil: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.7.7.3. Brazil: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.7.7.4. Brazil: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.7.7.5. Brazil: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.7.8. Biomarkers Market - Argentina
      • 10.7.8.1. Argentina: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.7.8.2. Argentina: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.7.8.3. Argentina: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.7.8.4. Argentina: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.7.8.5. Argentina: Biomarkers Market, by Application, 2020-2034 (USD Billion)
    • 10.7.9. Biomarkers Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Biomarkers Market, by Type, 2020-2034 (USD Billion)
      • 10.7.9.2. Rest of Latin America: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
      • 10.7.9.3. Rest of Latin America: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
      • 10.7.9.4. Rest of Latin America: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
      • 10.7.9.5. Rest of Latin America: Biomarkers Market, by Application, 2020-2034 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Abbott Laboratories
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Agilent Technologies, Inc.
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. BioMerieux SA
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Bio-Rad Laboratories, Inc.
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Charles River Laboratories International, Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Eurofins Scientific SE
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. F. Hoffmann-La Roche Ltd
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Guardant Health, Inc.
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Illumina, Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Merck KGaA
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. QIAGEN N.V.
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. Revvity, Inc.
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development

List of Tables:

  • Table 1 Global Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 3 Global Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 4 Global Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 5 Global Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 6 North America: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 7 North America: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 8 North America: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 9 North America: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 10 North America: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 11 U.S.: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 12 U.S.: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 13 U.S.: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 14 U.S.: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 15 U.S.: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 16 Canada: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 17 Canada: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 18 Canada: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 19 Canada: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 20 Canada: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 21 Europe: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 22 Europe: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 23 Europe: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 24 Europe: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 25 Europe: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 26 UK: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 27 UK: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 28 UK: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 29 UK: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 30 UK: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 31 France: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 32 France: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 33 France: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 34 France: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 35 France: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Germany: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 37 Germany: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 38 Germany: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 39 Germany: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 40 Germany: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 41 Italy: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 42 Italy: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 43 Italy: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 44 Italy: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 45 Italy: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 46 Spain: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 47 Spain: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 48 Spain: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 49 Spain: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 50 Spain: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Netherlands: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 52 Netherlands: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 53 Netherlands: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 54 Netherlands: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 55 Netherlands: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 56 Russia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 57 Russia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 58 Russia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 59 Russia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 60 Russia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 61 Rest of Europe: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Rest of Europe: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 63 Rest of Europe: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 64 Rest of Europe: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 65 Rest of Europe: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Asia Pacific: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 67 Asia Pacific: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 68 Asia Pacific: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 69 Asia Pacific: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 70 Asia Pacific: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 71 China: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 72 China: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 73 China: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 74 China: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 75 China: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 76 India: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 77 India: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 78 India: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 79 India: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 80 India: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 81 Malaysia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 82 Malaysia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 83 Malaysia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 84 Malaysia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 85 Malaysia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 86 Japan: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 87 Japan: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 88 Japan: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 89 Japan: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 90 Japan: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 91 Indonesia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Indonesia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 93 Indonesia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 94 Indonesia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 95 Indonesia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 96 South Korea: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 97 South Korea: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 98 South Korea: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 99 South Korea: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 100 South Korea: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 101 Australia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 102 Australia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 103 Australia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 104 Australia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 105 Australia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 106 Rest of Asia Pacific: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 107 Rest of Asia Pacific: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 108 Rest of Asia Pacific: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 109 Rest of Asia Pacific: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 110 Rest of Asia Pacific: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 111 Middle East & Africa: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 112 Middle East & Africa: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 113 Middle East & Africa: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 114 Middle East & Africa: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 115 Middle East & Africa: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 116 Saudi Arabia: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 117 Saudi Arabia: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 118 Saudi Arabia: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 119 Saudi Arabia: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 120 Saudi Arabia: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 121 UAE: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 122 UAE: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 123 UAE: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 124 UAE: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 125 UAE: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 126 Israel: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 127 Israel: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 128 Israel: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 129 Israel: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 130 Israel: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 131 South Africa: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 132 South Africa: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 133 South Africa: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 134 South Africa: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 135 South Africa: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 136 Rest of Middle East & Africa: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 137 Rest of Middle East & Africa: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 138 Rest of Middle East & Africa: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 139 Rest of Middle East & Africa: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 140 Rest of Middle East & Africa: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 141 Latin America: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 142 Latin America: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 143 Latin America: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 144 Latin America: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 145 Latin America: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 146 Mexico: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 147 Mexico: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 148 Mexico: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 149 Mexico: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 150 Mexico: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 151 Brazil: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 152 Brazil: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 153 Brazil: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 154 Brazil: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 155 Brazil: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 156 Argentina: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 157 Argentina: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 158 Argentina: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 159 Argentina: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 160 Argentina: Biomarkers Market, by Application, 2020-2034 (USD Billion)
  • Table 161 Rest of Latin America: Biomarkers Market, by Type, 2020-2034 (USD Billion)
  • Table 162 Rest of Latin America: Biomarkers Market, by Research Area, 2020-2034 (USD Billion)
  • Table 163 Rest of Latin America: Biomarkers Market, by Technology, 2020-2034 (USD Billion)
  • Table 164 Rest of Latin America: Biomarkers Market, by Disease Indication, 2020-2034 (USD Billion)
  • Table 165 Rest of Latin America: Biomarkers Market, by Application, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Biomarkers Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Biomarkers Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Research Area
  • Figure 9. Global Biomarkers Market, by Research Area, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Technology
  • Figure 11. Global Biomarkers Market, by Technology, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Disease Indication
  • Figure 13. Global Biomarkers Market, by Disease Indication, 2024 & 2034 (USD Billion)
  • Figure 14. Market by Application
  • Figure 15. Global Biomarkers Market, by Application, 2024 & 2034 (USD Billion)